Official Title : A Phase I Dose Escalation, Randomized, Open -Label Clinical Tri al to Evaluate Dose, Safety, 
Tolerability and Immunogenicity of a HIV -1 Vaccine, VRC -HIVRGP096 -00-VP, With Alum in Healthy Adults  
 
ClinicalTrials.gov Identifier : [STUDY_ID_REMOVED]  
 
Document Type : 
• Redacted Final Version of the Study Protocol (Statistical Analysis Considerations located in 
Section 6 of the Protocol)  
• Redacted  Final Version of  IRB-approved  Informed Consent  
 
Document/Date : 
• Protocol Version 3.0: September 3, 2019  
• Version 3.0 IRB -approved Informed Consent  (IRB approval: Sep tember 30, 2019)  